ID24374A - Komposisi-komposisi parenteral alatrofloksasin - Google Patents

Komposisi-komposisi parenteral alatrofloksasin

Info

Publication number
ID24374A
ID24374A IDW20000200A ID20000200A ID24374A ID 24374 A ID24374 A ID 24374A ID W20000200 A IDW20000200 A ID W20000200A ID 20000200 A ID20000200 A ID 20000200A ID 24374 A ID24374 A ID 24374A
Authority
ID
Indonesia
Prior art keywords
alatrofloxasin
parenteral compositions
parenteral
compositions
Prior art date
Application number
IDW20000200A
Other languages
English (en)
Inventor
Robert Mark Guinn
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24374A publication Critical patent/ID24374A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW20000200A 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin ID24374A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ID24374A true ID24374A (id) 2000-07-13

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000200A ID24374A (id) 1997-08-01 1998-07-23 Komposisi-komposisi parenteral alatrofloksasin

Country Status (40)

Country Link
US (1) US6194429B1 (id)
EP (1) EP1000086B1 (id)
JP (1) JP3463928B2 (id)
KR (1) KR20010022495A (id)
CN (1) CN1265671A (id)
AP (1) AP1031A (id)
AR (1) AR015417A1 (id)
AT (1) ATE259827T1 (id)
AU (1) AU734863B2 (id)
BG (1) BG104105A (id)
BR (1) BR9811580A (id)
CA (1) CA2296466C (id)
CO (1) CO4970688A1 (id)
DE (1) DE69821767T2 (id)
DK (1) DK1000086T3 (id)
DZ (1) DZ2576A1 (id)
EA (1) EA002120B1 (id)
ES (1) ES2214716T3 (id)
GT (1) GT199800112A (id)
HN (1) HN1998000106A (id)
HR (1) HRP980417B1 (id)
HU (1) HUP0004793A3 (id)
ID (1) ID24374A (id)
IL (1) IL134156A0 (id)
IS (1) IS5339A (id)
MA (1) MA24626A1 (id)
NO (1) NO20000485L (id)
NZ (1) NZ502249A (id)
OA (1) OA11281A (id)
PA (1) PA8456701A1 (id)
PE (1) PE103799A1 (id)
PL (1) PL338477A1 (id)
PT (1) PT1000086E (id)
SK (1) SK1012000A3 (id)
TN (1) TNSN98146A1 (id)
TW (1) TW538043B (id)
UY (1) UY25113A1 (id)
WO (1) WO1999006430A1 (id)
YU (1) YU2500A (id)
ZA (1) ZA986874B (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE285821T1 (de) * 1999-10-08 2005-01-15 Affinium Pharm Inc Fab i inhibitoren
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
CA2444597A1 (en) 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
DE602004016831D1 (de) 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
EP2848614A3 (en) 2004-06-04 2015-07-29 Debiopharm International SA Acrylamide derivatives as antibiotic agents
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
SI2861608T1 (sl) 2012-06-19 2019-08-30 Debiopharm International Sa Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid
EP3134103B1 (en) * 2014-04-25 2020-01-15 Naurex Inc. Stable compositions of neuroactive peptides
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
CN111971292B (zh) 2018-02-02 2024-12-13 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
CN113939306B (zh) 2019-06-14 2024-07-19 德彪药业国际股份公司 用于治疗涉及生物膜的细菌感染的药物及其用途
WO2021024041A1 (en) 2019-08-07 2021-02-11 Ripple Therapeutics Corporation Controlled release drug dimers
MX2022013665A (es) 2020-05-01 2022-11-30 Ripple Therapeutics Corp Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CZ286896B6 (en) 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
US5763454A (en) 1995-06-06 1998-06-09 Pfizer, Inc. Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
ATE221544T1 (de) * 1995-06-15 2002-08-15 Pfizer Verfahren zur herstellung von derivaten der ein peptid enthaltenden azabizylo-naphtyridin- carbonsäure
SK23898A3 (en) 1995-08-29 1999-05-07 Pfizer Zwitterionic forms of trovafloxacin
DE69617027T2 (de) * 1995-08-29 2002-03-21 Pfizer Inc., New York Polymorphs von prodrug 6-n(l-ala-l-ala)-trovafloxacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
HRP980417A2 (en) 1999-08-31
JP3463928B2 (ja) 2003-11-05
TNSN98146A1 (fr) 2005-03-15
BG104105A (bg) 2000-08-31
EA200000086A1 (ru) 2000-08-28
JP2001512133A (ja) 2001-08-21
HUP0004793A3 (en) 2001-10-29
DK1000086T3 (da) 2004-05-17
BR9811580A (pt) 2000-08-22
NO20000485D0 (no) 2000-01-31
NO20000485L (no) 2000-03-27
IS5339A (is) 2000-01-14
GT199800112A (es) 2000-01-15
EP1000086A1 (en) 2000-05-17
EA002120B1 (ru) 2001-12-24
AU8236898A (en) 1999-02-22
CO4970688A1 (es) 2000-11-07
YU2500A (sh) 2002-09-19
HUP0004793A2 (hu) 2001-04-28
AR015417A1 (es) 2001-05-02
US6194429B1 (en) 2001-02-27
ATE259827T1 (de) 2004-03-15
DZ2576A1 (fr) 2003-02-22
NZ502249A (en) 2001-11-30
DE69821767T2 (de) 2005-01-13
KR20010022495A (ko) 2001-03-15
IL134156A0 (en) 2001-04-30
AP1031A (en) 2001-12-21
OA11281A (en) 2002-11-19
DE69821767D1 (de) 2004-03-25
AU734863B2 (en) 2001-06-21
PL338477A1 (en) 2000-11-06
ZA986874B (en) 2000-01-31
CA2296466A1 (en) 1999-02-11
TW538043B (en) 2003-06-21
SK1012000A3 (en) 2000-09-12
EP1000086B1 (en) 2004-02-18
CN1265671A (zh) 2000-09-06
WO1999006430A1 (en) 1999-02-11
PA8456701A1 (es) 2000-05-24
CA2296466C (en) 2003-04-15
HRP980417B1 (en) 2002-10-31
AP9801310A0 (en) 1998-09-30
ES2214716T3 (es) 2004-09-16
HN1998000106A (es) 1999-01-08
PT1000086E (pt) 2004-05-31
MA24626A1 (fr) 1999-04-01
PE103799A1 (es) 1999-10-25
UY25113A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
ID22931A (id) Komposisi-komposisi herbisidal
DK1298194T3 (da) Staniolholdige sammensætninger
ID16251A (id) Komposisi-komposisi pembasmi kuman
PT945132E (pt) Composicao de ibuprofeno
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
FI974241L (fi) BPM-15 -koostumukset
DE69803761D1 (de) Schmierölzusammensetzungen
DE69919953D1 (de) Funktionelle zusammensetzungen
ATE469550T1 (de) Antiparasitäre zusammensetzungen
ID25508A (id) Komposisi dematologis
ID24458A (id) Modifikasi rheologi in-sito poliolefin
PT1014987E (pt) Composicoes orais de levosimendano
DE69935172D1 (de) Imidosilan Zusammensetzungen
ID24374A (id) Komposisi-komposisi parenteral alatrofloksasin
ATE209959T1 (de) Mikroverkapselte zusammensetzungen
DE69733072D1 (de) Farbschonende zusammensetzungen
DE69617029D1 (de) Organoton-zusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
NO984662L (no) Vann-i-olje-emulsjonsgj°dningsstoff-sammensetninger
DK0975348T3 (da) Stabiliserede tibolon-sammensætninger
ID25650A (id) Komposisi-komposisi sampo